PMA supplement
P050038 S038: Arista™ AH Absorbable Hemostatic Particles device
FDA PMA supplement · 135 Review Track For 30-Day Notice · Davol, Inc.
Key facts
| Original PMA | P050038 |
|---|---|
| Supplement number | S038 |
| Supplement type | 135 Review Track For 30-Day Notice |
| Reason for the supplement | Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| Trade name | Arista™ AH Absorbable Hemostatic Particles device |
| Generic name | Agent, absorbable hemostatic, non-collagen based |
| Applicant | Davol, Inc. |
| Product code | LMG |
| Received date | May 17, 2021 |
| Decision date | Oct 22, 2021 |
At a glance
- No Expedited review granted
- No Approval order on file
- No Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: